Company / SG&A per Share
NovoCure Ltd SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.64
FY2025
5-year range
$0.86 / $1.77
FY2021-FY2025
Trend
-7.6%
vs FY2024
Sector context
#121 of 156
Health Care
What the data says
NovoCure Ltd's sg&a per share of $1.64 is lower than 78% of companies in the Health Care sector (FY2025). Increased from $1.56 to $1.64 over the past 2 years.
Based on SEC 10-K filings.
1.64 in FY2025 with a 5-year CAGR of +17.3%.
Increased from $1.56 to $1.64 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +16.6%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 156This company $1.64 Sector average $11421.53
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 7.6% year-over-year.
- Ranks #121 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.64 | -7.6% |
| FY2024 | $1.77 | +13.5% |
| FY2023 | $1.56 | +51.1% |
| FY2022 | $1.03 | +20.2% |
| FY2021 | $0.86 | +16.4% |
| FY2020 | $0.74 | +16.4% |
| FY2019 | $0.63 | +11.2% |
| FY2018 | $0.57 | +46.6% |
| FY2017 | $0.39 | +35.5% |
| FY2016 | $0.29 | -76.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026